Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 181,385 | 636,056 | 481,062 | 270,664 | 76,021 |
| Depreciation Amortization | 22,977 | 74,909 | 51,999 | 31,325 | 16,027 |
| Income taxes - deferred | -79,785 | -121,623 | -65,975 | -59,069 | -37,256 |
| Accounts receivable | -397,428 | -491,421 | -462,943 | -418,753 | -329,746 |
| Other Working Capital | -225,795 | 229,827 | 246,295 | -317,849 | -269,086 |
| Other Operating Activity | 543,635 | 1,003,032 | 798,519 | 649,786 | 442,313 |
| Operating Cash Flow | $44,989 | $1,330,780 | $1,048,957 | $156,104 | $-101,727 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 60,409 | -229,668 | -284,147 | -147,075 | -15,319 |
| PPE Investments | -104,094 | -677,933 | -500,154 | -354,055 | -114,162 |
| Investing Cash Flow | $-43,685 | $-907,601 | $-784,301 | $-501,130 | $-129,481 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 27,373 | N/A | 26,780 | 6,738 |
| Debt Repayment | -2,337 | -741,307 | -119,602 | -144,001 | -141,217 |
| Common Stock Issued | -202,813 | 206,358 | -373,064 | -8,706 | 76,273 |
| Common Stock Repurchased | -1,042 | -160,537 | -71,673 | -35,930 | -21,192 |
| Other Financing Activity | 0 | 405,317 | 305,551 | 248,718 | 169,794 |
| Financing Cash Flow | $-206,192 | $-262,796 | $-258,788 | $86,861 | $90,396 |
| Beginning Cash Position | 809,102 | 648,719 | 648,719 | 648,719 | 648,719 |
| End Cash Position | 604,214 | 809,102 | 654,587 | 390,554 | 507,907 |
| Net Cash Flow | $-204,888 | $160,383 | $5,868 | $-258,165 | $-140,812 |
| Free Cash Flow | |||||
| Operating Cash Flow | 44,989 | 1,330,780 | 1,048,957 | 156,104 | -101,727 |
| Capital Expenditure | -104,094 | -677,933 | -500,154 | -354,055 | -114,162 |
| Free Cash Flow | -59,105 | 652,847 | 548,803 | -197,951 | -215,889 |